TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling. Ding X, Jin Y, Shi X, Wang Y, et al. Biochem Pharmacol 2024 Mar 27:116172. doi: 10.1016/j.bcp.2024.116172.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding X, Jin Y, Shi X, Wang Y, et al. TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling. Biochem Pharmacol 2024 Mar 27:116172. doi: 10.1016/j.bcp.2024.116172.
PMID: 38552852